Abbott Laboratories

NYSE:ABT   3:59:57 PM EDT
109.10
-0.35 (-0.32%)
Products

FDA, On Review Of Abbott Infant Formula Complaints, Says Was Notified Of 1 Additional Complaint On June 10 That Resulted In An Infant Death In Jan

Published: 06/22/2022 20:06 GMT
Abbott Laboratories (ABT) - FDA, on Review of Abbott Infant Formula Complaints, Says Was Notified of 1 Additional Complaint on June 10 That Resulted in an Infant Death in Jan.
FDA Says Agency Has Initiated an Investigation, Given That Complaint Referenced That Infant Had Consumed an Abbott Product.
FDA Says Investigation of Most Recent Consumer Complaint is in Preliminary Stages and Agency Will Provide an Update.